Key Dates

Related Announcements

PAR-21-063 - NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)

PAR-21-064 - NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)

NOT-DC-22-002 - Notice of Informational Webinar for PAR-21-063 and PAR-21-064: Planning to Consult with the Clinical and Translational Science Award (CTSA) Trial Innovation Network (TIN) (RESCINDED)

NOT-DC-21-006 - Notice of Invitation for Applicants to NIDCD PAR-21-063 and PAR-21-064 to Consult with the NCATS Clinical and Translational Science Award (CTSA) Trial Innovation Network (TIN) Prior to Submission (RESCINDED)

NOT-DC-22-004 - Notice to rescind NOT-DC-22-002, "Notice of Informational Webinar for PAR-21-063 and PAR-21-064: Planning to Consult with the Clinical and Translational Science Award (CTSA) Trial Innovation Network (TIN)"

Issued by

National Institute on Deafness and Other Communication Disorders (NIDCD)

Purpose

The purpose of this Notice is to rescind NOT-DC-21-006, "Notice of Invitation for Applicants to NIDCD PAR-21-063 and PAR-21-064 to Consult with the NCATS Clinical and Translational Science Award (CTSA) Trial Innovation Network (TIN) Prior to Submission", effective immediately.  Check back with our website for future updates (https://www.nidcd.nih.gov/research/clinical-studies/researchers-professionals/clinical-trials-overview).

Inquiries

Please direct all inquiries to:

Mary Purucker, MD, PhD
National Institute on Deafness and Other Communication Disorders (NIDCD)
Division of Scientific Programs (DSP)
Telephone: 240-285-8793
Email: [email protected]